Prevalence of drug use during sex amongst MSM in Europe: Results from a multi-site bio-behavioural survey

Authors: Rosińska M, Gios L, Nöstlinger C, Vanden Berghe W, Marcus U, Schink S, Sherriff N, Jones AM, Folch C, Dias S, Velicko I, Mirandola M
Publication Year: 2018
Journal: International Journal of Drug Policy
Link: https://www.ncbi.nlm.nih.gov/pubmed/29402683

Background: Substance use has been consistently reported to be more prevalent amongst Men who have Sex with Men (MSM) compared to the general population. Substance use, in particular polydrug use, has been found to be influenced by social and contextual factors and to increase the risk of unprotected intercourse among MSM. The objective of this […]
Read More

HIV serostatus knowledge and serostatus disclosure with the most recent anal intercourse partner in a European MSM sample recruited in 13 cities: results from the Sialon-II study

Authors: Alexiev I, Berglund T, Dias SF, Folch C, Gama AF, Gios L, Jones AM, Klavs I, Marcus U, Mirandola M, Naseva E, Niedźwiedzka-Stadnik M, Nöstlinger C, Pitigoi D, Rafila A, Schink SB, Sherriff N, Sialon II Network, Staneková D, Toskin I
Publication Year: 2017
Journal: BMC Infectious Diseases
Link: https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-017-2814-x/open-peer-review

Knowledge of HIV status can be important in reducing the risk of HIV exposure. In a European sample of men-who-have-sex-with-men (MSM), we aimed to identify factors associated with HIV serostatus disclosure to the most recent anal intercourse (AI) partner. We also aimed to describe the impact of HIV serostatus disclosure on HIV exposure risks. During […]
Read More

Prevalence of drug use during sex amongst MSM in Europe: Results from a multi-site bio-behavioural survey

HIV serostatus knowledge and serostatus disclosure with the most recent anal intercourse partner in a European MSM sample recruited in 13 cities: results from the Sialon-II study

About GHTM

Contacts

Map